Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.
The investigator hypothesizes that stellate ganglion blockade with local anesthetic performed prior to cardiac surgery will reduce the incidence and duration of postoperative atrial fibrillation (POAF).
Specific Aim 1: Determine the incidence of POAF in patients receiving pre-surgical stellate ganglion blockade with local anesthetic versus saline placebo within one week of surgery or during hospitalization if discharged prior to one week.
Specific Aim 2: Determine the duration of POAF in patients receiving pre-surgical stellate ganglion blockade with local anesthetic versus saline placebo within one week of surgery or during hospitalization if discharged prior to one week.
Specific Aim 3: Determine the success rate of the block as evaluated by ipsilateral hand temperature change and skin sympathetic nerve activity (SKNA).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stellate ganglion block with local anesthetic | Experimental | Subjects will receive a single injection of bupivacaine in a stellate ganglion block |
|
| Stellate ganglion block with saline placebo | Sham Comparator | Subjects will receive a single injection of saline in a stellate ganglion block |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stellate ganglion block | Procedure | Ultrasound guided injection into the stellate ganglion performed in the right side of the neck in a sterile fashion. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of atrial fibrillation | Percentage of subjects to experience postoperative atrial fibrillation (POAF) | Within one week of surgery or during hospitalization if discharged prior to one week |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of atrial fibrillation | Duration of postoperative atrial fibrillation (POAF) | Within one week of surgery or during hospitalization if discharged prior to one week |
| Skin Sympathetic Nerve Activity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Erica Wittwer, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Bupivacaine | Drug | 10 mL of 0.5% without epinephrine injected in the plane of the right stellate ganglion |
|
| Placebo | Drug | 10 mL of saline injected in the plane of the right stellate ganglion |
|
Measurement of difference in skin sympathetic nerve activity following block
| 10-30 minute following performance of nerve block |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D000588 |
| Amines |